Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 429
Open Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

Mechanisms Controlling PD-L1 Expression in Cancer
Jong‐Ho Cha, Li-Chuan Chan, Chia‐Wei Li, et al.
Molecular Cell (2019) Vol. 76, Iss. 3, pp. 359-370
Open Access | Times Cited: 748
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 287-305
Closed Access | Times Cited: 334
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
Li-Chuan Chan, Chia‐Wei Li, Weiya Xia, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3324-3338
Open Access | Times Cited: 293
Metabolic interventions in the immune response to cancer
David O’Sullivan, David E. Sanin, Edward J. Pearce, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 324-335
Closed Access | Times Cited: 239
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 197
Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
Florian Perner, Caroline Perner, Thomas Ernst, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 854-854
Open Access | Times Cited: 188
Emerging role of natural products in cancer immunotherapy
Songtao Dong, Xiangnan Guo, Fei Han, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1163-1185
Open Access | Times Cited: 173
Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
Amy L. Shergold, Rhona Millar, Robert J. B. Nibbs
Pharmacological Research (2019) Vol. 145, pp. 104258-104258
Open Access | Times Cited: 147
Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 115
Genetic basis and molecular profiling in myeloproliferative neoplasms
Damien Luque Paz, Róbert Královics, Radek C. Skoda
Blood (2022) Vol. 141, Iss. 16, pp. 1909-1921
Open Access | Times Cited: 83
The theory of tumor ecosystem
Xueman Chen, Erwei Song
Cancer Communications (2022) Vol. 42, Iss. 7, pp. 587-608
Open Access | Times Cited: 78
STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
Ze-Wei Huang, Xuening Zhang, Ling Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
Paolo A. Ascierto, Milena Casula, Jenny Bulgarelli, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 39
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
Lukas M. Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Cancer Cell (2025) Vol. 43, Iss. 2, pp. 269-291.e19
Open Access | Times Cited: 2
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
Nuzhat Ahmed, Ruth M. Escalona, Dilys T.H. Leung, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 265-281
Open Access | Times Cited: 134
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
Hao Sun, Si‐Yang Maggie Liu, Jiaying Zhou, et al.
EBioMedicine (2020) Vol. 60, pp. 102990-102990
Open Access | Times Cited: 134
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Shaima’a Hamarsheh, Lena Oßwald, Benedikt S. Saller, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 125
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Luqing Tong, Jiabo Li, Qiuying Li, et al.
Theranostics (2020) Vol. 10, Iss. 13, pp. 5943-5956
Open Access | Times Cited: 113
Noninvasive PET Imaging of T cells
Weijun Wei, Dawei Jiang, Emily B. Ehlerding, et al.
Trends in cancer (2018) Vol. 4, Iss. 5, pp. 359-373
Open Access | Times Cited: 109
Leukemia secondary to myeloproliferative neoplasms
Andrew Dunbar, Raajit K. Rampal, Ross L. Levine
Blood (2020) Vol. 136, Iss. 1, pp. 61-70
Open Access | Times Cited: 108
Targeting immune checkpoints in hematological malignancies
Basit Salik, Mark J. Smyth, Kyohei Nakamura
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 106
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
Hans Carl Hasselbalch, Morten Orebo Holmström
Seminars in Immunopathology (2018) Vol. 41, Iss. 1, pp. 5-19
Open Access | Times Cited: 87
miR-146a Controls Immune Response in the Melanoma Microenvironment
Justin Mastroianni, Natalie Stickel, Hana Andrlová, et al.
Cancer Research (2018) Vol. 79, Iss. 1, pp. 183-195
Open Access | Times Cited: 87
Lysyl Oxidase‐Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis
Hor‐Yue Tan, Ning Wang, Cheng Zhang, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2326-2341
Open Access | Times Cited: 86
Molecular pathogenesis of the myeloproliferative neoplasms
Graeme Greenfield, Mary Frances McMullin, Ken Mills
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top